165 related articles for article (PubMed ID: 26234429)
1. PAX1 methylation as an auxiliary biomarker for cervical cancer screening: a meta-analysis.
Nikolaidis C; Nena E; Panagopoulou M; Balgkouranidou I; Karaglani M; Chatzaki E; Agorastos T; Constantinidis TC
Cancer Epidemiol; 2015 Oct; 39(5):682-6. PubMed ID: 26234429
[TBL] [Abstract][Full Text] [Related]
2. Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer.
Xu J; Xu L; Yang B; Wang L; Lin X; Tu H
Int J Clin Exp Pathol; 2015; 8(2):1674-81. PubMed ID: 25973053
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the diagnostic performance of PAX1/SOX1 gene methylation in cervical precancerous lesions and its role in triage diagnosis.
Fan C; Hu J; Luo T; Dong B; Li H; Wang W; Yan J; Cai H
J Med Virol; 2024 May; 96(5):e29521. PubMed ID: 38727013
[TBL] [Abstract][Full Text] [Related]
4. Real-time colorimetric detection of DNA methylation of the
Huang J; Liou YL; Kang YN; Tan ZR; Peng MJ; Zhou HH
Int J Nanomedicine; 2016; 11():5335-5347. PubMed ID: 27789946
[TBL] [Abstract][Full Text] [Related]
5. PAX1 methylation as a potential biomarker for cervical cancer screening.
Kan YY; Liou YL; Wang HJ; Chen CY; Sung LC; Chang CF; Liao CI
Int J Gynecol Cancer; 2014 Jun; 24(5):928-34. PubMed ID: 24844223
[TBL] [Abstract][Full Text] [Related]
6. Real time quantitative methylation detection of PAX1 gene in cervical cancer screening.
Liu H; Meng X; Wang J
Int J Gynecol Cancer; 2020 Oct; 30(10):1488-1492. PubMed ID: 32616628
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
[TBL] [Abstract][Full Text] [Related]
8. PAX1 Methylation as a Potential Biomarker to Predict the Progression of Cervical Intraepithelial Neoplasia: A Meta-analysis of Related Studies.
Luan T; Hua Q; Liu X; Xu P; Gu Y; Qian H; Yan L; Xu X; Geng R; Zeng X; Li P
Int J Gynecol Cancer; 2017 Sep; 27(7):1480-1488. PubMed ID: 28472814
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
[TBL] [Abstract][Full Text] [Related]
10. PAX1 Methylation Hallmarks Promising Accuracy for Cervical Cancer Screening in Asians: Results from a Meta-Analysis.
Kong LY; Du W; Wang L; Yang Z; Zhang HS
Clin Lab; 2015; 61(10):1471-9. PubMed ID: 26642709
[TBL] [Abstract][Full Text] [Related]
11. PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study.
Lai HC; Ou YC; Chen TC; Huang HJ; Cheng YM; Chen CH; Chu TY; Hsu ST; Liu CB; Hung YC; Wen KC; Yu MH; Wang KL
Cancer Med; 2014 Aug; 3(4):1062-74. PubMed ID: 24799352
[TBL] [Abstract][Full Text] [Related]
12. The application value of PAX1 and ZNF582 gene methylation in high grade intraepithelial lesion and cervical cancer.
Liang H; Li GL; Liu J; Fu M; Huang H; Zhao K; Wei Y; Xiao J
Clin Transl Oncol; 2021 Feb; 23(2):283-288. PubMed ID: 32514824
[TBL] [Abstract][Full Text] [Related]
13. Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm.
Chang CC; Huang RL; Liao YP; Su PH; Hsu YW; Wang HC; Tien CY; Yu MH; Lin YW; Lai HC
BMC Cancer; 2015 May; 15():418. PubMed ID: 25985991
[TBL] [Abstract][Full Text] [Related]
14. PAX1 and SEPT9 methylation analyses in cervical exfoliated cells are highly efficient for detecting cervical (pre)cancer in hrHPV-positive women.
He L; Luo X; Bu Q; Jin J; Zhou S; He S; Zhang L; Lin Y; Hong X
J Obstet Gynaecol; 2023 Dec; 43(1):2179916. PubMed ID: 36799003
[TBL] [Abstract][Full Text] [Related]
15. Methylated
Su Y; Tang Y; Zhang T; Xu Y; Zhang Y; Shen Y; Qin L; Zhang L; Cao L; Zhou Y; Liou Y; Zhang M
Future Oncol; 2022 Jul; 18(23):2583-2592. PubMed ID: 35758002
[TBL] [Abstract][Full Text] [Related]
16. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis.
Kelly H; Benavente Y; Pavon MA; De Sanjose S; Mayaud P; Lorincz AT
Br J Cancer; 2019 Nov; 121(11):954-965. PubMed ID: 31616037
[TBL] [Abstract][Full Text] [Related]
17. PAX1 and SOX1 methylation as an initial screening method for cervical cancer: a meta-analysis of individual studies in Asians.
Chen Y; Cui Z; Xiao Z; Hu M; Jiang C; Lin Y; Chen Y
Ann Transl Med; 2016 Oct; 4(19):365. PubMed ID: 27826568
[TBL] [Abstract][Full Text] [Related]
18. Genotype-specific methylation of HPV in cervical intraepithelial neoplasia.
Hsu YW; Huang RL; Su PH; Chen YC; Wang HC; Liao CC; Lai HC
J Gynecol Oncol; 2017 Jul; 28(4):e56. PubMed ID: 28541643
[TBL] [Abstract][Full Text] [Related]
19. PAX1 methylation analysis by MS-HRM is useful in triage of high-grade squamous intraepithelial lesions.
Wang ZM
Asian Pac J Cancer Prev; 2014; 15(2):891-4. PubMed ID: 24568514
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel DNA methylation markers in cervical cancer.
Lai HC; Lin YW; Huang TH; Yan P; Huang RL; Wang HC; Liu J; Chan MW; Chu TY; Sun CA; Chang CC; Yu MH
Int J Cancer; 2008 Jul; 123(1):161-7. PubMed ID: 18398837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
